143 related articles for article (PubMed ID: 36994848)
1. Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhu X; Yang Y; Zhou L; Gong H; Xu C; Tao L
Acta Otolaryngol; 2023 Apr; 143(4):317-321. PubMed ID: 36994848
[TBL] [Abstract][Full Text] [Related]
2. Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
Gong H; Zhou L; Wu H; Tao L; Zhang M; Chen X; Li X; Li C; Zhou J; Wang S
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):353-358. PubMed ID: 32633609
[TBL] [Abstract][Full Text] [Related]
3. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
4. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
5. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
Kalfert D; Celakovsky P; Laco J; Ludvikova M
Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
[TBL] [Abstract][Full Text] [Related]
6. [Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
Gong H; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):316-320. PubMed ID: 33794628
[No Abstract] [Full Text] [Related]
7. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
[TBL] [Abstract][Full Text] [Related]
8. pT3 N0 Laryngeal Squamous Cell Carcinoma: Oncologic Outcomes and Prognostic Factors of Surgically Treated Patients.
Mattioli F; Fermi M; Molinari G; Capriotti V; Melegari G; Bertolini F; D'Angelo E; Tirelli G; Presutti L
Laryngoscope; 2021 Oct; 131(10):2262-2268. PubMed ID: 33755212
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pathological tumor size in patients with supraglottic carcinoma.
Gong H; Zhou L; Hsueh CY; Wu H; Tao L; Zhang M; Chen X; Li C; Mo M; Zhou J
Am J Otolaryngol; 2021; 42(1):102757. PubMed ID: 33128995
[TBL] [Abstract][Full Text] [Related]
10. Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery.
Kayhan FT; Koc AK; Erdim I
Auris Nasus Larynx; 2019 Apr; 46(2):285-293. PubMed ID: 30217617
[TBL] [Abstract][Full Text] [Related]
11. WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
Oncol Rep; 2017 Oct; 38(4):2062-2068. PubMed ID: 28849066
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
13. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
14. Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery.
Hakeem AH; Tubachi J; Pradhan SA
Laryngoscope; 2013 Aug; 123(8):1912-7. PubMed ID: 23606304
[TBL] [Abstract][Full Text] [Related]
15. Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy.
Pakkanen P; Irjala H; Ilmarinen T; Halme E; Lindholm P; Mäkitie A; Wigren T; Aaltonen LM
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):96-100. PubMed ID: 35164976
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma.
Jumaily M; Faraji F; Osazuwa-Peters N; Walker RJ; Ward GM
Oral Oncol; 2019 Oct; 97():105-111. PubMed ID: 31473467
[TBL] [Abstract][Full Text] [Related]
17. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
18. Paraglottic Space Invasion in Glottic Laryngeal Cancer: A Clinical-Pathological Study.
Fermi M; Lo Manto A; Di Massa G; Gallo G; Lupi M; Maiolo V; Montrone G; Lovato L; Presutti L; Mattioli F
Laryngoscope; 2023 May; 133(5):1184-1190. PubMed ID: 37042776
[TBL] [Abstract][Full Text] [Related]
19. Association between pathological differentiation and survival outcomes of patients with laryngeal squamous cell carcinoma.
Zhu Y; Shi X; Zhu X; Diao W; Chen X
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4595-4604. PubMed ID: 35581439
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients.
Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM
Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
